LabTurbo Biotech Corporation (7725) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for LabTurbo Biotech Corporation (7725:TWSE), powered by AI.

Current Price
$23.15
P/E Ratio
85.8
Market Cap
1.1B
Sector
Healthcare
What is the LabTurbo Biotech Corporation stock price forecast?

LabTurbo Biotech Corporation is currently trading at $23.15. View real-time AI analysis on Alpha Lenz.

What is LabTurbo Biotech Corporation insider trading activity?

View the latest insider trading data for LabTurbo Biotech Corporation on Alpha Lenz.

What is LabTurbo Biotech Corporation's P/E ratio?

LabTurbo Biotech Corporation's P/E ratio is 85.8.

LabTurbo Biotech Corporation

NT$23.15
TWSE7725
Ask about LabTurbo Biotech Corporation's future dividend policy...
Alpha Chat Insight

LabTurbo Biotech Corporation trades at a P/E of 85.8 (premium valuation) with modest ROE of 1.0%.

Ask for details

Company Overview

LabTurbo Biotech Corporation is a biotechnology company specializing in the research, development, and manufacturing of fully automated precision medical genetic testing systems and reagent kits. Established in 2000 and headquartered in Taipei, Taiwan, the company provides advanced solutions for nucleic acid extraction and molecular diagnostic testing, serving hospitals and clinical laboratories across Taiwan, the United States, Europe, the Middle East, and Southeast Asia. Its core product line, including the LabTurbo AIO and QuadAIO systems, offers high-throughput, automated genetic testing designed to improve the accuracy, speed, and standardization of diagnostic workflows. LabTurbo is recognized for its innovative approach to precision diagnostics, holding numerous international patents and having received national awards for innovation and research. The company’s technology supports applications in infectious disease detection, genetic screening, and precision medicine, reflecting its pivotal role in modern healthcare diagnostics and the global expansion of molecular testing capabilities.

SectorHealthcare
IndustryBiotechnology
0

Company Statistics

(FY 2024)

Profile

Market CapNT$1.11B
RevenueNT$72.97M
Shares Out0.00
Employees0

Margins

Gross23.33%
EBITDA78.92%
Operating-250.10%
Pre-Tax10.59%
Net17.76%

Valuation

P/E85.80
P/B0.85
EV/Sales15.24
EV/EBITDA16.75
P/FCF-7.92

Growth (CAGR)

Rev 3Yr-57.92%
Rev 5YrN/A
Op Inc 3YrN/A
Op Inc 5YrN/A
Net Inc 3Yr-69.54%
Net Inc 5YrN/A

Returns

ROA0.93%
ROE0.98%
ROIC0.59%

Financial Health

Cash & Cash EquivalentsNT$175.62M
Net DebtNT$-99.49M
Debt/Equity5.80%
Interest CovN/A
Ask Alpha Chat

Frequently Asked Questions

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
LabTurbo Biotech Corporation (Healthcare) Stock Forecast & Analysis $23.15 | Alpha Lenz